Levoxyl®- Home

Terms of Access for the Levoxyl^® Website

MM_XSLTransform error:
"http://www.kingpharm.com/kingpharm/data/TermsOfAccess.xml" is not a valid XML document.
reason: End tag 'HEAD' does not match the start tag 'META'.
error code: -1072896659
file position: 416
line: 11
character position: 3

WARNING: Thyroid hormones, including Levoxyl^®, either alone or together with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In patients with a normal functioning thyroid gland, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may provide serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic based weight loss drugs.

Levoxyl^® is indicated for thyroid hormone replacement or supplemental therapy for hypothyroidism. Levoxyl^® is contraindicated in patients with untreated thyrotoxicosis, acute myocardial infarction, uncorrected adrenal insufficiency, or hypersensitivity to any of its inactive ingredients. Levoxyl^® is protected by U.S. Patent Number 6,555,581

Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdose. Use with caution in patients with cardiovascular disease.

For a full list of adverse reactions, please see full prescribing information.

©2001-2009 King Pharmaceuticals,^® Inc., 501 Fifth Street, Bristol, TN 37620. All rights reserved.
Levoxyl^® is a registered trademark of King Pharmaceuticals Research and Development, Inc.
Accudose is a registered trademark of Monarch Pharmaceuticals,^® Inc.
Monarch Pharmaceuticals^® and King Pharmaceuticals Research and Development are wholly owned subsidiaries of King Pharmaceuticals,^® Inc.

Terms of Access for the Levoxyl® Website

Terms of Access for the Levoxyl^® Website